Globus Medical, Inc.
GMED
#1810
Rank
$11.157 B
Marketcap
United States
Country
$83.10
Share price
-2.41%
Change (1 day)
32.64%
Change (1 year)
Globus Medical, Inc. develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products comprising traditional fusion implants, such as pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices; treatment options for motion preservation technologies consisting of dynamic…
Key Metrics
Trailing P/E
18.95
Forward P/E
13.72
EPS (TTM)
$3.91
Forward EPS
$5.40
Price / Book
2.09
EV / EBITDA
9.4x
Beta
0.96
Dividend Yield
—
Return on Equity
11.81%
Return on Assets
8.74%
Debt / Equity
2.35
Current Ratio
4.62
Gross Margin
68.97%
Operating Margin
24.75%
Net Profit Margin
17.03%
Free Cash Flow
$554.195M
Charts
Price history and financial performance over time.
Price & Market Cap
Aug 19 – Sep 18
-16.14%
Source: Yahoo Finance daily closes. Market cap uses the closest quarterly shares-outstanding filing for each date.
Revenue & Net Income
Annual · USD
RevenueNet Income
Latest Revenue$2.939B
Latest Net Income$537.868M
Reporting periods4
Source: Yahoo Finance annual income statements. Year is the fiscal-year end. Most recent period may be trailing-twelve-month (TTM) until the next 10-K is filed.
Compare Globus Medical, Inc. with competitors
Side-by-side market cap, revenue, and financial comparison.
Latest News
Latest News
GMED
No recent news available. Set FINNHUB_API_KEY to enable news.
